May 18, 2014

MAb polishing step development using Capto™ adhere ImpRes in bind-elute mode


With tighter and tighter timelines in the development of downstream processes for biopharmaceuticals, developing a platform approach has become increasingly important. The similar properties of monoclonal antibodies (MAbs) allow for such a platform approach to processing, based on the wealth of information available from a wide variety of MAb applications.

Tags: biopharmaceutical production; bio process development, bind-elute, Capto, MAb polishing